Amgen plows ahead with costly, highly toxic cancer dosing despite FDA challenge

FHS
May 7, 2024
10:38 am

When doctors began using the drug sotorasib in 2021 with high expectations for its innovative approach to attacking lung cancer, retired medical technician Don Crosslin was an early beneficiary.

Prenatal cannabis exposure increases risk of adverse birth outcomes, study finds

Infants prenatally exposed to cannabis are more likely to be born preterm, have a low birth weight, and require neonatal intensive care unit (NICU) care

November 16, 2023

ED Clinicians Tackle Patients’ Food Insecurity, Homelessness

PHILADELPHIA — Emergency departments trying to help patients with social problems such as food insecurity and housing insecurity are meeting with varying degrees of success,

October 12, 2023

Vor Biopharma’s ‘shielded’ transplant delays relapse in leukemia patients

A CRISPR-augmented stem cell transplant that protects healthy cells from the toxic effects of anti-cancer medicines has shown preliminary evidence that it can delay relapse

September 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.